Moderna Says its Booster Increases Omicron Neutralizing Antibody Levels
Vaccine maker Moderna, which is at the forefront of developing messenger RNA (mRNA) therapeutics and vaccines, announced today that according
Read moreVaccine maker Moderna, which is at the forefront of developing messenger RNA (mRNA) therapeutics and vaccines, announced today that according
Read moreEvusheld, a long-acting antibody (LAAB) combination from AstraZeneca, has received emergency use authorisation (EUA) by the FDA in the United
Read morePreliminary laboratory studies have shown that three doses of the Pfizer-BioNTech COVID-19 Vaccine can neutralize the Omicron variant (B.1.1.529 lineage),
Read moreA new Oxford-GSK Institute of Molecular and Computational Medicine will be established through a substantial five-year cooperation between GlaxoSmithKline plc
Read moreLeading vaccine producers have stated that new vaccines will be developed if necessary to meet the demand of governments worldwide
Read moreThe US Centers for Disease Control and Prevention (CDC) has recommended the use of COVID-19 vaccine boosters for everyone 18
Read moreA next-generation COVID-19 vaccine, developed by British biotech Emergex, designed to prime T-Cells to rapidly remove viral-infected cells and offer
Read moreNew Phase 3 Data has shown a positive correlation between the human monoclonal antibody ADUHELM™ treatment effect on biomarkers and
Read moreMerck (MRK) and Ridgeback Biotherapeutics have announced that the Japanese government will acquire approximately 1.6 million courses of molnupiravir (MK-4482,
Read moreThe world’s most vulnerable populations are given access to COVID-19 vaccines thanks to the COVAX Humanitarian Buffer. Johnson & Johnson
Read more